OpenAI said on June 17 that its general-purpose reasoning model GPT-5.4 drove a medicinal chemistry project from literature review through to a validated experimental result, discovering an unexpected way to improve a widely used reaction, according to its announcement. The model was paired with Molecule.one's high-throughput robotic synthesis platform "Maria AI" and a specialized lab, completing roughly 10,000 reactions and human bench-scale verification over about three months.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.